NCT06786299
Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
Phase: Early Phase 1
Role: Collaborator
Start: Feb 10, 2025
Completion: Dec 31, 2026